News

FDA says it will phase out animal testing requirement for monoclonal antibodies and drugs
The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies ...
Sanofi flunks mid-stage trial for asthma drug
Sanofi (NASDAQ:SNY) announced Tuesday that its TIDE-Asthma Phase 2 study for its T-cell-depleting monoclonal antibody ...
FDA Announces Plan to Phase Out Some Animal Testing
To achieve these ends, the FDA will use computer modeling and artificial intelligence (AI) to predict a drug’s behavior and ...
We’re on the verge of a universal allergy cure
Two-thirds of Americans report spring allergies, and about 4 in 10 say they take an allergy medication several times a week. But those medicines, while valuable, don’t exactly fix the problem. One ...
FDA phasing out some animal testing in 'win-win' for ethics and public health: commissioner
The FDA is phasing out an animal testing requirement for monoclonal antibody therapies in favor of testing drugs on ...
Medscape1d
Monoclonal Antibodies in Rheumatoid Arthritis
No writing assistance was utilized in the production of this manuscript. Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA).
MedCity News4d
FDA Phase Out of Animal Test Requirements for Drugs Begins With Biologics
The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...
To promote drug safety, FDA to replace animal testing with AI-based experiments, other methods
The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...
Inotiv drops after FDA says phasing out animal testing of monoclonal antibodies
Shares of Inotiv (NOTV) were down $1.39, or 50%, to $1.42 near the close of trading after the Food and Drug Administration announced that it is ...
Managed Healthcare Executive14d
Monoclonal Antibody Bentracimab Shown to Reverse Antiplatelet Effect of Brilinta | ACC 2025
A BLA has been filed for bentracimab and, if approved, has the potential to be the first therapy to reverse the effects of Brilinta for patients who have bleeding events or who need urgent surgery.
FDA to phase out animal testing requirements
The Food and Drug Administration said it will phase out a requirement that certain drugs and monoclonal antibodies be tested ...
Charles River Labs Stock (CRL) Crashes 28% as FDA Signals End of Animal Testing Era
Shares of Charles River Labs (CRL) crashed 28% after the U.S. FDA (Food and Drug Administration) announced plans to phase out the need for ...